Sponsors > Sponsors

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, hematology, immunology, cardiovascular and fibrosis.
Merck Merck
From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - Merck is everywhere. Our advanced treatment solutions and innovative technology are life-changing, influencing how we tackle major illnesses and integral to creating a better tomorrow. From cancer therapies and laboratory tools to smartphones, science and technology touch our lives.
Roche Roche
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.
Sanofi Sanofi
Sanofi is an innovative global healthcare company. Sanofi provides potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Arsep Arsep
L'ARSEP, créée en 1969, est une Fondation reconnue d'utilité publique à but non lucratif dont la mission, depuis plus de 50 ans, est de contribuer à la prévention et au traitement de la Sclérose en Plaques, par la Recherche, l'enseignement et l'information auprès du public.
Bordeaux Neurocampus Bordeaux Neurocampus
Bordeaux Neurocampus missions are: Research and innovation / Training: for students (masters, PhD) through the Graduate Program, for researchers (hands-on trainings) with the School of Neurosciences / Scientific dissemination: towards researchers, with weekly seminars or the yearly international conference and towards the general audience, during national events (Science week…)
Bind Bind
Launched in 2014, the Bordeaux Initiative for Neurodegenerative Disorders (ND) « BIND » is led by the University of Bordeaux. It aims at bounding multiple disciplines and ND, along a continuum from preclinical to clinical research to improve care provision. This patient-centred, centripetal and transdisciplinary initiative for ND will rely on a core of recognized excellence and will promote links with other disciplines.
Région Nouvelle Aquitaine Région Nouvelle Aquitaine
Au quotidien, la Région Nouvelle-Aquitaine est engagée dans plusieurs démarches de service public. L'institution s'engage pour l'égalité femme-homme et le respect de la déontologie. Elle met en œuvre des démarches de concertation et d'évaluation de ses politiques publiques.
Online user: 2 Privacy